Nonalcoholicsteatohepatitis (NASH) Pipeline Analysis - Forecast to 2026; New Report Launched
Non-alcoholic steatohepataitis (NASH) Pipeline Analysis gives comprehensive insights on the various drugs being developed for the treatment of NASH. The report covers all the drugs that are in various phases of development (Discovery, Preclinical & Clinical). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, antibodies, stem cell therapies, recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations and supplemental drugs. The report also covers some of the hot targets in research for...
View full press release